Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.132
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.481
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
8.81×10-05
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
6.37×10-06
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0492
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.331
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
3.11×10-05
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.854
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HET
|
1f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0213
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.374
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:25m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
1.41×10-07
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.719
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.899
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.720
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0197
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.243
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.909
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0355
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.566
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.494
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.769
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0292
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0383
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0587
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0884
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0361
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0396
|
Successful |
Trip13em1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0405
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.331
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0836
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.398
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.218
|
Successful |
Trip13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
3f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.107
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.489
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.859
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.755
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0171
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
7.52×10-06
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.175
|
Successful |
Trip13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
3f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.389
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.604
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.125
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.380
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0845
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.184
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.154
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.399
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.797
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00734
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.590
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00113
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0496
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00730
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.905
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.761
|
Successful |
Trip13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
3f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.146
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.383
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.623
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0390
|
Successful |
Trip13em1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0392
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.289
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.370
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.182
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.550
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.302
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.988
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.242
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.431
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00154
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.836
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.884
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.901
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HET
|
1f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.482
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.966
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.290
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:30m
|
|
|
NotProcessed |
Trip13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
15f:30m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:40m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.27×10-06
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
7.50×10-07
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0379
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0605
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HET
|
1f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.187
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.269
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.102
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.537
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
4.70×10-06
|
Successful |
Trip13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00259
|
Successful |